Overview

Dapsone Prurigo Study

Status:
Unknown status
Trial end date:
2019-11-01
Target enrollment:
Participant gender:
Summary
Principal aim of this study is to assess whether a combination of topical dapsone and clobetasol as a topical steroid is superior to clobetasol alone as treatment of prurigo nodularis or lichen simplex chronicus in a side to side comparison. The study is primarily exploratory and essentially meant to inform the sponsor whether further development of a combination treatment formulation is warranted
Phase:
N/A
Details
Lead Sponsor:
John H. Stroger Hospital
Treatments:
Dapsone